GARDASIL 9 60 ug/.5mL

GARDASIL 9 is a 9-valent HPV vaccine designed to help prevent certain HPV-related conditions. This recombinant vaccine is administered intramuscularly and is available in a 60 µg/0.5 mL suspension form.

GARDASIL 9 is primarily used to help prevent infections caused by nine types of human papillomavirus (HPV). These types are known to cause various conditions, including cervical, vulvar, vaginal, and anal cancers, as well as genital warts. The vaccine is intended for use in individuals to help reduce the risk of these HPV-related health issues.

Common effects of GARDASIL 9 may include pain, swelling, or redness at the injection site. Some individuals might also experience headaches, fatigue, or mild fever following vaccination. These effects are generally mild and temporary.

GARDASIL 9 should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any existing medical conditions or allergies before receiving the vaccine.

GARDASIL 9 is generally considered safe with other vaccines, but it is recommended to administer it separately from other injectable vaccines. There is no known interaction with alcohol or food, but it is always best to follow the advice of a healthcare provider regarding any specific concerns.